;PMID: 2501680
;source_file_649.mrg
;Release 0.9 of PennBioIE
;Funded by NSF ITR EIA-0205448

;0)section:[e:0..33] = [t:0..33]
;1)sentence:[e:39..229] = [t:39..229]
;2)section:[e:233..330] = [t:233..330]
;3)section:[e:334..446] = [t:334..446]
;4)sentence:[e:450..566] = [t:450..566]
;5)sentence:[e:567..682] = [t:567..682]
;6)sentence:[e:683..787] = [t:683..787]
;7)sentence:[e:788..968] = [t:788..968]
;8)sentence:[e:969..1148] = [t:969..1148]
;9)sentence:[e:1149..1265] = [t:1149..1265]
;10)sentence:[e:1266..1454] = [t:1266..1454]
;11)section:[e:1458..1502] = [t:1458..1502]

;section 0 Span:0..33
;Mutat Res. 1989 Jul;226(3):163-7.
(SEC
  (FRAG (NNP:[0..5] Mutat) (NNP:[6..9] Res) (.:[9..10] .) (CD:[11..15] 1989)
        (CC:[16..22] Jul;22) (CD:[22..23] 6) (NN:[23..24] -LRB-) (NN:[24..25] 3)
        (NN:[25..26] -RRB-) (VBZ:[26..27] :) (CD:[27..29] 16) (CD:[29..32] 3-7)
        (.:[32..33] .)))

;sentence 1 Span:39..229
;Interspecies homology of cytochrome P-450: toxicological significance of 
;cytochrome P-450 cross-reactive with anti-rat P-448-H antibodies in liver 
;microsomes from dogs, monkeys and humans.
;[64..80]:cyp450:"cytochrome P-450"
;[113..129]:cyp450:"cytochrome P-450"
;[150..177]:substance:"anti-rat P-448-H antibodies"
(SENT
  (NP-HLN
    (NP
      (NP (JJ:[39..51] Interspecies) (NN:[52..60] homology))
      (PP (IN:[61..63] of)
        (NP (NN:[64..74] cytochrome) (NN:[75..80] P-450))))
    (::[80..81] :)
    (NP
      (NP (JJ:[82..95] toxicological) (NN:[96..108] significance))
      (PP (IN:[109..111] of)
        (NP
          (NP (NN:[113..123] cytochrome) (NN:[124..129] P-450))
          (RRC
            (ADJP (AFX:[130..135] cross) (HYPH:[135..136] -)
                  (JJ:[136..144] reactive))
            (PP (IN:[145..149] with)
              (NP
                (ADJP (AFX:[150..154] anti) (HYPH:[154..155] -)
                      (NN:[155..158] rat) (NN:[159..166] P-448-H))
                (NNS:[167..177] antibodies)))
            (PP-LOC (IN:[178..180] in)
              (NP
                (NP (NN:[181..186] liver) (NNS:[188..198] microsomes))
                (PP (IN:[199..203] from)
                  (NP (NNS:[204..208] dogs) (,:[208..209] ,)
                      (NNS:[210..217] monkeys) (CC:[218..221] and)
                      (NNS:[222..228] humans)))))))))
    (.:[228..229] .)))

;section 2 Span:233..330
;Ohta K, Kitada M, Ohi H, Komori M, Nagashima K, Sato N, Muroya K, Kodama T, 
;Nagao M, Kamataki T.
(SEC
  (FRAG (NNP:[233..237] Ohta) (NNP:[238..240] K,) (NNP:[241..247] Kitada)
        (NNP:[248..250] M,) (NNP:[251..254] Ohi) (NNP:[255..257] H,)
        (NNP:[258..264] Komori) (NNP:[265..267] M,) (NNP:[268..277] Nagashima)
        (NNP:[278..280] K,) (NNP:[281..285] Sato) (NNP:[286..287] N)
        (,:[287..288] ,) (NNP:[289..295] Muroya) (NNP:[296..298] K,)
        (NNP:[299..305] Kodama) (NNP:[306..307] T) (,:[307..308] ,)
        (NNP:[310..315] Nagao) (NNP:[316..318] M,) (NNP:[319..327] Kamataki)
        (NNP:[328..330] T.)))

;section 3 Span:334..446
;Department of Analytical Biochemistry, Faculty of Pharmaceutical Sciences, 
;Hokkaido University, Sapporo, Japan.
(SEC
  (FRAG (NNP:[334..344] Department) (IN:[345..347] of)
        (NNP:[348..358] Analytical) (NNP:[359..371] Biochemistry)
        (,:[371..372] ,) (NNP:[373..380] Faculty) (IN:[381..383] of)
        (NNP:[384..398] Pharmaceutical) (NNPS:[399..407] Sciences)
        (,:[407..408] ,) (NNP:[410..418] Hokkaido) (NNP:[419..429] University)
        (,:[429..430] ,) (NNP:[431..438] Sapporo) (,:[438..439] ,)
        (NNP:[440..445] Japan) (.:[445..446] .)))

;sentence 4 Span:450..566
;The mutagenic activation of various promutagens by liver microsomes from
;dogs,  monkeys and humans was investigated.
;[486..497]:substance:"promutagens"
(SENT
  (S
    (NP-SBJ-1
      (NP (DT:[450..453] The) (JJ:[454..463] mutagenic)
          (NN:[464..474] activation))
      (PP (IN:[475..477] of)
        (NP (JJ:[478..485] various) (NNS:[486..497] promutagens)))
      (PP (IN:[498..500] by)
        (NP
          (NP (NN:[501..506] liver) (NNS:[507..517] microsomes))
          (PP (IN:[518..522] from)
            (NP (NNS:[523..527] dogs) (,:[527..528] ,) (NNS:[530..537] monkeys)
                (CC:[538..541] and) (NNS:[542..548] humans))))))
    (VP (VBD:[549..552] was)
      (VP (VBN:[553..565] investigated)
        (NP-1 (-NONE-:[565..565] *))))
    (.:[565..566] .)))

;sentence 5 Span:567..682
;Dog liver microsomes efficiently catalyzed  the mutagenic activation of
;Trp-P-2 and Glu-P-1 followed by IQ and AAF.
;[639..646]:substance:"Trp-P-2"
;[651..658]:substance:"Glu-P-1"
;[671..673]:substance:"IQ"
;[678..681]:substance:"AAF"
(SENT
  (S
    (NP-SBJ (NN:[567..570] Dog) (NN:[571..576] liver)
            (NNS:[577..587] microsomes))
    (ADVP (RB:[588..599] efficiently))
    (VP (VBD:[600..609] catalyzed)
      (NP
        (NP (DT:[611..614] the) (JJ:[615..624] mutagenic)
            (NN:[625..635] activation))
        (PP (IN:[636..638] of)
          (NP
            (NP (NN:[639..646] Trp-P-2) (CC:[647..650] and)
                (NN:[651..658] Glu-P-1))
            (VP (VBN:[659..667] followed)
              (NP-1 (-NONE-:[667..667] *))
              (PP (IN:[668..670] by)
                (NP-LGS (NN:[671..673] IQ) (CC:[674..677] and)
                        (NN:[678..681] AAF))))))))
    (.:[681..682] .)))

;sentence 6 Span:683..787
;Monkey  liver microsomes were most active in the activation of IQ followed by
;Glu-P-1,  AAF and Trp-P-2.
;[746..748]:substance:"IQ"
;[761..768]:substance:"Glu-P-1"
;[771..774]:substance:"AAF"
;[779..786]:substance:"Trp-P-2"
(SENT
  (S
    (NP-SBJ (NN:[683..689] Monkey) (NN:[691..696] liver)
            (NNS:[697..707] microsomes))
    (VP (VBD:[708..712] were)
      (ADJP-PRD (RBS:[713..717] most) (JJ:[718..724] active))
      (PP (IN:[725..727] in)
        (NP
          (NP (DT:[728..731] the) (NN:[732..742] activation))
          (PP (IN:[743..745] of)
            (NP
              (NP (NN:[746..748] IQ))
              (VP (VBN:[749..757] followed)
                (NP-1 (-NONE-:[757..757] *))
                (PP (IN:[758..760] by)
                  (NP-LGS (NN:[761..768] Glu-P-1) (,:[768..769] ,)
                          (NN:[771..774] AAF) (CC:[775..778] and)
                          (NN:[779..786] Trp-P-2)))))))))
    (.:[786..787] .)))

;sentence 7 Span:788..968
;Although there were remarkable individual differences, human  liver
;microsomes were found to be most active in the mutagenic activation of IQ 
;followed by Trp-P-2, Glu-P-1 and AAF.
;[927..929]:substance:"IQ"
;[943..950]:substance:"Trp-P-2"
;[952..959]:substance:"Glu-P-1"
;[964..967]:substance:"AAF"
(SENT
  (S
    (SBAR-ADV (IN:[788..796] Although)
      (S
        (NP-SBJ (EX:[797..802] there))
        (VP (VBD:[803..807] were)
          (NP-PRD (JJ:[808..818] remarkable) (JJ:[819..829] individual)
                  (NNS:[830..841] differences)))))
    (,:[841..842] ,)
    (NP-SBJ-1 (JJ:[843..848] human) (NN:[850..855] liver)
              (NNS:[856..866] microsomes))
    (VP (VBD:[867..871] were)
      (VP (VBN:[872..877] found)
        (S
          (NP-SBJ-1 (-NONE-:[877..877] *))
          (VP (TO:[878..880] to)
            (VP (VB:[881..883] be)
              (ADJP-PRD (RBS:[884..888] most) (JJ:[889..895] active))
              (PP (IN:[896..898] in)
                (NP
                  (NP (DT:[899..902] the) (JJ:[903..912] mutagenic)
                      (NN:[913..923] activation))
                  (PP (IN:[924..926] of)
                    (NP
                      (NP (NN:[927..929] IQ))
                      (VP (VBN:[931..939] followed)
                        (NP-2 (-NONE-:[939..939] *))
                        (PP (IN:[940..942] by)
                          (NP-LGS (NN:[943..950] Trp-P-2) (,:[950..951] ,)
                                  (NN:[952..959] Glu-P-1) (CC:[960..963] and)
                                  (NN:[964..967] AAF)))))))))))))
    (.:[967..968] .)))

;sentence 8 Span:969..1148
;Antibodies against rat P-448-H inhibited  the mutagenic activation of
;Glu-P-1, Trp-P-2 and IQ in rat and dog liver  microsomes, and Glu-P-1 and
;Trp-P-2 in monkey liver microsomes.
;[969..979]:substance:"Antibodies"
;[992..999]:substance:"P-448-H"
;[1039..1046]:substance:"Glu-P-1"
;[1048..1055]:substance:"Trp-P-2"
;[1060..1062]:substance:"IQ"
;[1101..1108]:substance:"Glu-P-1"
;[1113..1120]:substance:"Trp-P-2"
(SENT
  (S
    (NP-SBJ
      (NP (NNS:[969..979] Antibodies))
      (PP (IN:[980..987] against)
        (NP (NN:[988..991] rat) (NN:[992..999] P-448-H))))
    (VP
      (VP (VBD:[1000..1009] inhibited)
        (NP
          (NP (DT:[1011..1014] the) (JJ:[1015..1024] mutagenic)
              (NN:[1025..1035] activation))
          (PP (IN:[1036..1038] of)
            (NP=2 (NN:[1039..1046] Glu-P-1) (,:[1046..1047] ,)
                  (NN:[1048..1055] Trp-P-2) (CC:[1056..1059] and)
                  (NN:[1060..1062] IQ))))
        (PP-LOC=3 (IN:[1063..1065] in)
          (NP
            (NP (NN:[1066..1069] rat)
              (NML-1 (-NONE-:[1069..1069] *P*)))
            (CC:[1070..1073] and)
            (NP (NN:[1074..1077] dog)
              (NML-1 (NN:[1078..1083] liver) (NNS:[1085..1095] microsomes))))))
      (,:[1095..1096] ,) (CC:[1097..1100] and)
      (VP
        (NP=2 (NN:[1101..1108] Glu-P-1) (CC:[1109..1112] and)
              (NN:[1113..1120] Trp-P-2))
        (PP-LOC=3 (IN:[1121..1123] in)
          (NP (NN:[1124..1130] monkey) (NN:[1131..1136] liver)
              (NNS:[1137..1147] microsomes)))))
    (.:[1147..1148] .)))

;sentence 9 Span:1149..1265
;The activation  of Glu-P-1 and IQ in human liver microsomes was also strongly
;inhibited by  anti-P-448-H antibodies.
;[1168..1175]:substance:"Glu-P-1"
;[1180..1182]:substance:"IQ"
;[1241..1264]:substance:"anti-P-448-H antibodies"
(SENT
  (S
    (NP-SBJ-1
      (NP (DT:[1149..1152] The) (NN:[1153..1163] activation))
      (PP (IN:[1165..1167] of)
        (NP (NN:[1168..1175] Glu-P-1) (CC:[1176..1179] and) (NN:[1180..1182] IQ)))
      (PP-LOC (IN:[1183..1185] in)
        (NP (JJ:[1186..1191] human) (NN:[1192..1197] liver)
            (NNS:[1198..1208] microsomes))))
    (VP (VBD:[1209..1212] was)
      (ADVP (RB:[1213..1217] also))
      (ADVP (RB:[1218..1226] strongly))
      (VP (VBN:[1227..1236] inhibited)
        (NP-1 (-NONE-:[1236..1236] *))
        (PP (IN:[1237..1239] by)
          (NP-LGS
            (ADJP (AFX:[1241..1245] anti) (HYPH:[1245..1246] -)
                  (NN:[1246..1253] P-448-H))
            (NNS:[1254..1264] antibodies)))))
    (.:[1264..1265] .)))

;sentence 10 Span:1266..1454
;The amounts of cytochrome P-450 cross-reactive with  anti-P-448-H antibodies
;in human liver microsomes highly correlated with the  capacity to activate
;Glu-P-1, Trp-P-2 and IQ but not AAF.
;[1281..1297]:cyp450:"cytochrome P-450"
;[1319..1342]:substance:"anti-P-448-H antibodies"
;[1418..1425]:substance:"Glu-P-1"
;[1427..1434]:substance:"Trp-P-2"
;[1439..1441]:substance:"IQ"
;[1450..1453]:substance:"AAF"
(SENT
  (S
    (NP-SBJ
      (NP (DT:[1266..1269] The) (NNS:[1270..1277] amounts))
      (PP (IN:[1278..1280] of)
        (NP
          (NP (NN:[1281..1291] cytochrome) (NN:[1292..1297] P-450))
          (RRC
            (ADJP (AFX:[1298..1303] cross) (HYPH:[1303..1304] -)
                  (JJ:[1304..1312] reactive))
            (PP (IN:[1313..1317] with)
              (NP
                (ADJP (AFX:[1319..1323] anti) (HYPH:[1323..1324] -)
                      (NN:[1324..1331] P-448-H))
                (NNS:[1332..1342] antibodies)))
            (PP-LOC (IN:[1343..1345] in)
              (NP (JJ:[1346..1351] human) (NN:[1352..1357] liver)
                  (NNS:[1358..1368] microsomes)))))))
    (ADVP (RB:[1369..1375] highly))
    (VP
      (VP (VBD:[1376..1386] correlated)
        (PP-CLR (IN:[1387..1391] with)
          (NP (DT:[1392..1395] the) (NN:[1397..1405] capacity)
            (S
              (NP-SBJ (-NONE-:[1405..1405] *))
              (VP (TO:[1406..1408] to)
                (VP (VB:[1409..1417] activate)
                  (NP=1 (NN:[1418..1425] Glu-P-1) (,:[1425..1426] ,)
                        (NN:[1427..1434] Trp-P-2) (CC:[1435..1438] and)
                        (NN:[1439..1441] IQ))))))))
      (VP (CC:[1442..1445] but) (RB:[1446..1449] not)
        (NP=1 (NN:[1450..1453] AAF))))
    (.:[1453..1454] .)))

;section 11 Span:1458..1502
;PMID: 2501680 [PubMed - indexed for MEDLINE]
(SEC
  (FRAG (NNP:[1458..1462] PMID) (::[1462..1463] :) (CD:[1464..1471] 2501680)
        (NN:[1472..1473] -LSB-) (NNP:[1473..1479] PubMed) (::[1480..1481] -)
        (NN:[1482..1489] indexed) (IN:[1490..1493] for)
        (NNP:[1494..1502] MEDLINE-RSB-)))
